Engineering Bispecific Antibodies

Incredible progress has been made to engineer bispecific antibodies using novel platforms and approaches to bring more molecules to the forefront of medicine that have the capacity to go beyond current limitations and advance cures for intractable diseases, including not only for oncology but also in infectious disease. Join this year’s luminary faculty at the 15th Annual Engineering Bispecific Antibodies: Achieving Unprecedented Efficacy conference at the PEGS Boston Summit, the original forum on this topic that showcases the advancement of engineering strategies for the creation of unique and efficacious bispecific antibody constructs.